View in EDS

A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma.

Saved in:
Bibliographic Details
Title: A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma.
Authors: Issa II; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark., Brøndum RF; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark., Due H; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark., Schmidt L; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark., Bøgsted M; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark., Dybkær K; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark.
Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2021 Mar 19; Vol. 4 (1), pp. 208-222. Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2578-532X
DOI:10.20517/cdr.2020.76